Lv2
110 积分 2024-10-25 加入
Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy
1个月前
已完结
Involvement of the PD-1 pathway in the modulation of immune responses during allergic diseases
1个月前
已完结
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
1个月前
已完结
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
1个月前
已完结
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial
1个月前
已完结
Epigenetic therapy in immune-oncology
2个月前
已完结
Abstract 1549: Molecular mechanism of CD146 nanobody in tumor metastasis inhibition mediating by IL-6/JAK/STAT3 signaling in triple-negative breast cancer
2个月前
已关闭
PD‐L2:PD‐1 involvement in T cell proliferation, cytokine production, and integrin‐mediated adhesion
3个月前
已完结
Cancer immunotherapy using checkpoint blockade
3个月前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
3个月前
已完结
皖公网安备34019202002308
